$XMTR

Miln James sold $132K of XMTR

Miln James (Chief Financial Officer) sold 1,500 shares of Xometry, Inc. (XMTR) at an average of $87.92 ($87.26–$90.28, $0.13M total) across 4 trades on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Miln James
Published Aug 7, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 10:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
high confidence
Mentioned
$XMTR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity, but it does not include new operational, financial, or regulatory information that would change valuation assumptions.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to be a standalone catalyst.

03

What to watch

The filing does not disclose reasons for the sale, and the transaction is spread across multiple trades at similar prices, consistent with planned execution rather than event-driven trading.

Relevance 3/10Novelty 3/10Timing: filed Aug. 7, covering sales executed Aug. 6

Background

The article is an SEC Form 4 insider transaction disclosure for Xometry, Inc. (XMTR) by its CFO.

Company-level read

Ticker impact

$XMTRNeutralHigh confidence
Context

CFO Miln James sold about $131.9K of Xometry shares via an open-market sale under a pre-arranged 10b5-1 plan on Aug. 6.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, and the disclosed size ($131.9K) is modest relative to typical market moves.

Market effects

No clear sector read-through from a single, small 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales under 10b5-1 can reflect liquidity planning rather than bearish expectations, so the market may overreact if it treats it as discretionary selling.

Key entities

  • Xometry, Inc.

    Public company whose CFO reported an open-market sale under a pre-arranged 10b5-1 plan.

  • Miln James

    Chief Financial Officer who executed the reported share sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.